Skip to main content

Table 2 Main effects of natural (previous infection) and induced (partial or complete vaccination) exposure to SARS-CoV-2 on the relative risk reduction (RRR) of the onset of any and symptomatic infections caused by delta and alpha variants, and corresponding 95% confidence interval

From: Protective action of natural and induced immunization against the occurrence of delta or alpha variants of SARS-CoV-2 infection: a test-negative case-control study

 

Controls

Delta cases

Alpha cases

 

N (%)

N (%)

RRR (95% CI) a

N (%)

RRR (95% CI) a

p value ‡

Any infection (symptomatic and asymptomatic together)

(N = 4960)

(N = 496)

(N = 496)

 

 Previous infection

  Unlike

4411 (88.9)

490 (98.8)

0% (reference)

487 (98.2)

0% (reference)

 

  Ascertained

549 (11.1)

6 (1.2)

90% (76% to 95%)

9 (1.8)

85% (70% to 92%)

0.547

 Vaccination

  No

2650 (53.4)

349 (70.4)

0% (reference)

402 (81.1)

0% (reference)

 

  Partial

876 (17.7)

93 (18.8)

29% (7% to 45%)

65 (13.1)

62% (48% to 71%)

0.001

  Complete

1434 (28.9)

54 (10.9)

75% (66% to 82%)

29 (5.8)

90% (85% to 94%)

0.003

Symptomatic (mild, severe, critical and fatal together) infection

(N = 3740)

(N = 374)

(N = 374)

 

 Previous infection

  Unlike

3332 (89.1)

371 (99.2)

0% (reference)

368 (98.4)

0% (reference)

 

  Ascertained

408 (10.9)

3 (0.8)

93% (79% to 98%)

6 (1.6)

87% (71% to 94%)

0.410

 Vaccination

  No

1996 (53.4)

269 (71.9)

0% (reference)

312 (83.4)

0% (reference)

 

  Partial

697 (18.6)

71 (19.0)

35% (12% to 51%)

46 (12.3)

66% (52% to 76%)

0.005

  Complete

1047 (28.0)

34 (9.1)

81% (71% to 87%)

16 (4.3)

93% (88% to 96%)

0.004

  1. a Relative risk reduction (RRR) calculated as 1- adjusted odds ratio. The latter was estimated with conditional logistic regression, adjusted for the number of previous contacts with the Regional Health Service, use of corticosteroids, drugs for chronic pain, oral anticoagulant agents and insulin, and the presence of anaemias, chronic respiratory disease, dyslipidaemia, depression, hypertension, coronary and peripheral vascular disease, hypothyroidism, epilepsy and recurrent seizures, psychosis, diabetes without insulin therapy, malignancies, other diseases of the respiratory system, other diseases of the digestive system, other diseases of the genitourinary system, gout, autoimmune disease, other diseases of the circulatory system, symptoms, signs and ill-defined conditions, diseases of the skin and subcutaneous tissues, arrhythmia, inflammatory bowel diseases, other mental disorders, heart failure, glaucoma and chronic kidney disease
  2. ‡ Chi-square testing the null hypothesis of between-variant homogeneity of the odds ratios